SCHEMBL7799239

SCHEMBL7799239

COc1cc2nc(N)nc(-c3cccc(F)c3F)c2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.51
EGFR P00533 1/20 0.46
KIT P10721 2/20 0.45
DHFR P00374 2/20 0.44
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 2/20 0.42
RAD52 P43351 2/20 0.42
MEN1 O00255 1/20 0.42
WHR1 P49842 1/20 0.42
CSF1R P07333 1/20 0.40
RPS6KA2 Q15349 1/20 0.40
DCPS Q96C86 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
NSD2 O96028 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791033 0.90 ADORA2A (0.61) ADORA2AEGFRKITDHFRTP53
SCHEMBL7799233 0.80 ADORA2A (0.62) ADORA2AEGFRDHFRMAPTKMT2A
SCHEMBL7799376 0.80 ADORA2A (0.51) ADORA2AEGFRDHFRTP53MAPT
SCHEMBL7790975 0.80 ADORA2A (0.51) ADORA2AEGFRDHFRTP53MAPT
SCHEMBL7791023 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRKMT2AMEN1
SCHEMBL7800422 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRTP53MAPT
SCHEMBL7790971 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRKMT2AMEN1
SCHEMBL7585771 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRTP53MAPT
SCHEMBL7799250 0.79 ADORA2A (0.53) ADORA2AEGFRDHFRWHR1HSP90AA1
SCHEMBL27420270 0.76 ACHE (0.52) ADORA2AEGFRDHFRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
EP-1162974-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056338-A1 QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed